Lehrstuhl für Haut- und Geschlechtskrankheiten

Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway (2018) Busch L, Mougiakakos D, Büttner-Herold M, Müller MJ, Volmer DA, Bach C, Fabri M, et al. Journal article MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients (2018) Kirchberger MC, Ugurel S, Mangana J, Heppt MV, Eigentler TK, Berking C, Schadendorf D, et al. Journal article Localized Scleroderma of the Head and Face Area: A Retrospective Cross-sectional Study of 96 Patients from 5 German Tertiary Referral Centres (2018) Kreuter A, Mitrakos G, Hofmann SC, Lehmann P, Sticherling M, Krieg T, Lahner N, et al. Journal article Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study (2018) Kampylafka E, D'Oliveira I, Linz C, Lerchen V, Stemmler F, Simon D, Englbrecht M, et al. Journal article Hypertonicity primes malignant melanoma cells for apoptosis (2018) Calance DN, Steixner C, Gross S, Schuler-Thurner B, Knoll G, Ehrenschwender M Journal article Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers? (2018) Sticherling M Journal article Patients' and Physicians' Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare) (2018) Schaarschmidt ML, Herr RM, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, Augustin M, Peitsch WK Journal article Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy (2018) Tajmir-Riahi A, Bergmann T, Schmid M, Agaimy A, Schuler G, Heinzerling L Journal article Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab (2017) Brueggemann C, Kirchberger MC, Goldinger SM, Weide B, Konrad A, Erdmann M, Schadendorf D, et al. Journal article RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma (2017) Harrer DC, Simon B, Fujii SI, Shimizu K, Uslu U, Schuler G, Gerer KF, et al. Journal article